Targeting TNF- for cancer therapy

Journal of Biology

Volumn 8, Issue 9, 2009, Pages

  Burton, Elizabeth R ^a   Libutti, Steven K ^b  

^a Division of Gynecologic Oncology   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN RECEPTOR; ANGIOSTATIN; ANTINEOPLASTIC AGENT; ANTITHROMBIN; CANSTATIN; CHYMASE; ENDOSTATIN; EPHRIN; EPHRIN RECEPTOR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; HEPARANASE; HYBRID PROTEIN; INTEGRIN; MATRIX METALLOPROTEINASE; NEUROPEPTIDE Y; PLASMIN; PLASMINOGEN ACTIVATOR; PLATELET DERIVED GROWTH FACTOR; RETINA S ANTIGEN; SCATTER FACTOR; THROMBIN; THROMBOPLASTIN; THYMIDINE PHOSPHORYLASE; TIE 1 RECEPTOR; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; UROKINASE; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; SMALL INTERFERING RNA;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; BASEMENT MEMBRANE; CANCER THERAPY; CELL MIGRATION; CELL PROLIFERATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE THERAPY; MICROENVIRONMENT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PUBLICATION; SCIENTIFIC LITERATURE; SHORT SURVEY; STOMACH CANCER; STROMA; TUMOR VASCULARIZATION; ANIMAL; APOPTOSIS; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MOUSE; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); SIGNAL TRANSDUCTION; STOMACH TUMOR; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70449447887     PISSN: None     EISSN: 14754924     Source Type: Journal    
DOI: 10.1186/jbiol189     Document Type: Short Survey

References (15)

1. Stromagenesis: The changing face of fibroblastic microenvironments during tumor progression. DA Beacham E Cukierman, Semin Cancer Biol 2005 15 329 341 10.1016/j.semcancer.2005.05.003 15970443
2. Fibroblasts in cancer. R Kalluri M Zeisberg, Nat Rev Cancer 2006 6 392 401 10.1038/nrc1877 16572188
3. Tumor stroma and regulation of cancer development. TD Tlsty LM Coussens, Annu Rev Pathol Mech Dis 2006 1 119 150 10.1146/annurev.pathol.1.110304.100224
4. A review on pro- and anti-angiogenic factors as targets of clinical intervention. D Bouis Y Kusumanto C Meijer NH Mulder GA Hospers, Pharmacol Res 2006 53 89 103 10.1016/j.phrs.2005.10.006 16321545
5. National Cancer Institute. http://www.cancer.gov/
6. Tumour necrosis factor a: a potential target for the therapy of solid tumours. PW Szlosarek FR Balkwill, Lancet Oncol 2004 4 565 573 10.1016/S1470-2045(03)01196-3
7. A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapy. B Chen C Shanshan Y Zhang X Wang J Liu X Hui Y Wan W Du L Wang K Wu D Fan, BMC Cell Biol 2009 10 63 10.1186/1471-2121-10-63 19740430
8. Tumor vasculature-targeted delivery of tumor necrosis factor-alpha. A Tandle E Hanna D Lorang A Hajitou CA Moya R Pasqualini W Arap A Adem E Starker S Hewitt SK Libutti, Cancer 2009 115 128 139 10.1002/cncr.24001 19090007
9. Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNF alpha to cancer vasculature. MC Paoloni A Tandle C Mazcko E Hanna S Kachala A Leblanc S Newman D Vail C Henry D Thamm K Sorenmo A Hajitou R Pasqualini W Arap C Khanna SK Libutti, PLoS One 2009 4 4972 10.1371/journal.pone.0004972 19330034
10. Tumor stroma-associated antigens for anti-cancer immunotherapy. V Hofmeister C Vetter D Schrama EB Brocker JC Becker, Cancer Immunol Immunother 2006 55 481 494 10.1007/s00262-005-0070-1 16220326
11. Alpha v integrins as receptors for tumor targeting by circulating ligands. R Pasqualini E Koivunen E Ruoslahti, Nat Biotechnol 1997 15 542 546 10.1038/nbt0697-542 9181576
12. The neovasculature homing motif NGR: more than meets the eye. A Corti F Curnis W Arap R Pasqualini, Blood 2008 112 2628 2635 10.1182/blood-2008-04- 150862 18574027
13. A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo. K Porkka P Laakkonen JA Hoffman M Bernasconi E Ruoslahti, Proc Natl Acad Sci USA 2002 99 7444 7449 10.1073/pnas.062189599 12032302
14. Characterization of a specific phage-displayed peptide binding to vasculature of human gastric cancer. M Zhiu KC Wu L Dong ZM Hao TZ Deng L Hong SH Liang PT Zhao TD Qiao Y Wang X Xu DM Fan, Cancer Biol Ther 2004 3 1232 1235 15492500
15. Progress in antiangiogenic gene therapy of cancer. AL Feldman SK Libutti, Cancer 2000 89 1181 1194 10.1002/1097-0142(20000915)89:6<1181::AID- CNCR1>3.0.CO;2-T 11002212